Clinical Trial Update: Effect of CBD on the Brain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial led by Université de Sherbrooke is evaluating the effects of cannabidiol (CBD) on brain function in Fragile X syndrome; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Fragile X Syndrome | Phase 2 | Status: NOT_YET_RECRUITING